Difference in severity of porcine circovirus type two-induced pathological lesions between Landrace and Pietrain pigs by Opriessnig, Tanja I. et al.
Animal Science Publications Animal Science
2009
Difference in severity of porcine circovirus type
two-induced pathological lesions between
Landrace and Pietrain pigs
Tanja I. Opriessnig
Iowa State University, tanjaopr@iastate.edu
A. R. Patterson
Iowa State University
Darin M. Madson
Iowa State University, madson@iastate.edu
N. Pal
Iowa State University
Max F. Rothschild
Iowa State University, mfrothsc@iastate.edu
See next page for additional authors
Follow this and additional works at: http://lib.dr.iastate.edu/ans_pubs
Part of the Agriculture Commons, Animal Sciences Commons, Genetics and Genomics
Commons, and the Veterinary Medicine Commons
The complete bibliographic information for this item can be found at http://lib.dr.iastate.edu/
ans_pubs/249. For information on how to cite this item, please visit http://lib.dr.iastate.edu/
howtocite.html.
This Article is brought to you for free and open access by the Animal Science at Iowa State University Digital Repository. It has been accepted for
inclusion in Animal Science Publications by an authorized administrator of Iowa State University Digital Repository. For more information, please
contact digirep@iastate.edu.
Difference in severity of porcine circovirus type two-induced pathological
lesions between Landrace and Pietrain pigs
Abstract
Anecdotal information from the field suggests that there are host genetic differences in susceptibility to
porcine circovirus type 2 (PCV2) associated disease among Landrace and Pietrain breeds. The objective of
this study was to determine if a difference exists in PCV2 susceptibility between Landrace and Pi-etrain pigs
under experimental conditions. Thirty-nine Landrace pigs and 39 Pietrain pigs were blocked by breed, sire,
dam, and litter and randomly divided into the following 4 groups: Landrace noninoculated negative control
(Landrace-NEG; n = 13), Pietrain noninoculated negative control (Pietrain-NEG; n = 13), Landrace-PCV2
(n = 26; Landrace), and Pietrain-PCV2 (n = 26; Pietrain). After waning of passively acquired anti-PCV2
antibodies, Landrace-PCV2 and Pietrain-PCV2 groups were inoculated with PCV2 isolate ISU-40895. The
Landrace-NEG and Pietrain-NEG groups were housed in a separate room, remained noninoculated, and
served as negative controls. All pigs in all groups were necropsied at 21 d post PCV2-inoculation. Onset of
seroconversion and concentrations of anti-PCV2-IgM, anti-PCV2-IgG, and anti-PCV2 neutralizing
antibodies were similar in Landrace-PCV2 and Pietrain-PCV2 groups. Furthermore, the amount of PCV2
DNA and cytokine concentrations in serum and plasma samples were not different between the 2
PCV2-inoculated groups. The severity of PCV2-associated microscopic lesions was different between
Landrace and Pietrain pigs; Landrace-PCV2 pigs had significantly (P < 0.05) more severe lymphoid lesions
than the Pietrain-PCV2 pigs. Although the pigs originated from the same farm where their dams were
commingled, passively acquired anti-PCV2-antibodies waned in Pietrain pigs by approximately 12 wk of age,
whereas the majority of the Landrace pigs remained PCV2 seropositive until 18 wk of age and beyond. The
results from this study indicate that a genetic difference exists between these 2 breeds of pigs in susceptibility
to PCV2-associated lesions.
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ABSTRACT: Anecdotal information from the field 
suggests that there are host genetic differences in sus-
ceptibility to porcine circovirus type 2 (PCV2) associ-
ated disease among Landrace and Pietrain breeds. The 
objective of this study was to determine if a difference 
exists in PCV2 susceptibility between Landrace and Pi-
etrain pigs under experimental conditions. Thirty-nine 
Landrace pigs and 39 Pietrain pigs were blocked by 
breed, sire, dam, and litter and randomly divided into 
the following 4 groups: Landrace noninoculated nega-
tive control (Landrace-NEG; n = 13), Pietrain nonin-
oculated negative control (Pietrain-NEG; n = 13), Lan-
drace-PCV2 (n = 26; Landrace), and Pietrain-PCV2 (n 
= 26; Pietrain). After waning of passively acquired anti-
PCV2 antibodies, Landrace-PCV2 and Pietrain-PCV2 
groups were inoculated with PCV2 isolate ISU-40895. 
The Landrace-NEG and Pietrain-NEG groups were 
housed in a separate room, remained noninoculated, 
and served as negative controls. All pigs in all groups 
were necropsied at 21 d post PCV2-inoculation. Onset 
of seroconversion and concentrations of anti-PCV2-IgM, 
anti-PCV2-IgG, and anti-PCV2 neutralizing antibod-
ies were similar in Landrace-PCV2 and Pietrain-PCV2 
groups. Furthermore, the amount of PCV2 DNA and 
cytokine concentrations in serum and plasma samples 
were not different between the 2 PCV2-inoculated 
groups. The severity of PCV2-associated microscopic 
lesions was different between Landrace and Pietrain 
pigs; Landrace-PCV2 pigs had significantly (P < 0.05) 
more severe lymphoid lesions than the Pietrain-PCV2 
pigs. Although the pigs originated from the same farm 
where their dams were commingled, passively acquired 
anti-PCV2-antibodies waned in Pietrain pigs by ap-
proximately 12 wk of age, whereas the majority of the 
Landrace pigs remained PCV2 seropositive until 18 wk 
of age and beyond. The results from this study indicate 
that a genetic difference exists between these 2 breeds 
of pigs in susceptibility to PCV2-associated lesions.
Key words:  breed, conventional pig model, genetic susceptibility, Landrace, Pietrain, porcine circovirus type 2
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INTRODUCTION
Porcine circovirus type 2 (PCV2) infection is char-
acterized by distinct lymphoid lesions such as depletion 
of lymphocytes and granulomatous inflammation (Sor-
den, 2000). Large amounts of PCV2 antigen or nucleic 
acids can be demonstrated in the cytoplasm of mac-
rophages and dendritic cells replacing lymphocytes in 
the depleted follicles (Allan and Ellis, 2000). Disease 
syndromes associated with PCV2 infection, including 
systemic infection or postweaning multisystemic wast-
ing syndrome (PMWS), respiratory disease, reproduc-
tive disorders, and enteric disease are summarized as 
PCV2-associated disease (PCVAD; Opriessnig et al., 
2007).
Anecdotal reports from the field suggest Landrace 
pigs are more susceptible to PCV2-infection and PC-
VAD compared with Pietrain pigs. However, controlled 
genetic studies on susceptibility to specific diseases are 
difficult to conduct due to size and cost limitations re-
sulting in restrictions on pigs per line and breed. It is 
well known that genetic components in disease resis-
tance exist in pigs such as reported with porcine re-
productive and respiratory syndrome virus (Halbur et 
al., 1998; Petry et al., 2005, 2007; Vincent et al., 2006), 
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pseudorabies virus (Reiner et al., 2002), Salmonella sp. 
(Wigley, 2004), and Escherichia coli (Duchet-Suchaux 
et al., 1991; Michaels et al., 1994).
Spanish scientists observed a trend toward genetic 
susceptibility and PCVAD in field studies involving cer-
tain paternal genetic backgrounds (Lopéz-Soria et al., 
2004; Sibila et al., 2005). In a controlled trial, Landrace 
pigs were found to develop more severe microscopic 
PCV2-associated lesions compared with Large White 
and Duroc pigs (Opriessnig et al., 2006a). However, a 
French group was not able to confirm the improvement 
of PCVAD using selected breeding with Pietrain sires 
(Rose et al., 2004).
The objective of the current study was to determine 
if a difference in severity of PCV2-induced pathologi-
cal lesions exists between conventional Landrace and 
Pietrain pigs.
MATERIALS AND METHODS
The experimental protocol in this study was approved 
by the Iowa State University Institutional Animal Care 
and Use Committee. 
Animals
A source herd for purebred Landrace and Pietrain 
pigs was identified. Based on routine serological test-
ing, the source herd was negative for porcine reproduc-
tive and respiratory syndrome virus and swine influ-
enza virus but positive for PCV2. However, PCVAD 
was not observed in the source herd or on the farms 
supplied with offspring from this herd. To fulfill study 
requirements, the following selective breeding was im-
plemented: A total of 13 Landrace sows and 13 Pietrain 
sows were used. For each breed, 6 different nonrelated 
sires were utilized resulting in 2 to 3 dams per sire and 
breed. From each litter, 3 random piglets were selected 
for the study resulting in a total of 39 Landrace piglets 
and 39 Pietrain piglets. Of the Landrace piglets, 20 
were male and 19 were female; of the Pietrain piglets, 
19 were male and 20 were female. The piglets of both 
breeds were born in the same barn under the same en-
vironmental and management conditions, were allowed 
to suckle colostrum, and were weaned at 3 wk of age, 
at which time they were brought to the research facility 
at Iowa State University.
Experimental Design and Housing
All pigs were commingled and raised in the same 
building and room at the research facility and were pe-
riodically monitored for presence of PCV2-antibodies. 
After waning of the maternal antibodies at approxi-
mately 21 wk of age, the pigs were blocked by litter 
and were distributed to 1 of 3 identical rooms. One 
pig from each litter served as a noninoculated negative 
control (Landrace-NEG, n = 13; Pietrain-NEG, n 
= 13), whereas the remaining 2 pigs from each litter 
were inoculated with PCV2 (Landrace-PCV2, n = 
26; Pietrain-PCV2, n = 26). Pietrain and Landrace 
pigs were randomly distributed across pens in each 
room and commingled within pens. The pens were 2.5 
× 3.6 m raised wire decks, which were equipped with 
1 nipple drinker and 1 self-feeder. All groups were fed 
ad libitum a balanced, pelleted, complete feed ration 
free of animal proteins and antibiotics (Nature’s Made, 
Heartland Coop, Prairie City, IA).
The Landrace-PCV2 and Pietrain-PCV2 groups were 
inoculated with PCV2 at 21 wk of age. The Landrace-
NEG and Pietrain-NEG groups remained noninoculat-
ed. After PCV2-inoculation, pigs were bled weekly for 3 
wk. Serum samples were tested for the presence of anti-
PCV2-IgG and -IgM antibodies, neutralizing antibod-
ies and PCV2 associated viremia, and plasma samples 
were tested for presence of selected cytokines. All pigs 
in all groups were necropsied at 21 d postinoculation 
(DPI).
Inoculation
The PCV2-isolate ISU-40895 (GenBank accession 
number AF264042) originally isolated in 1998 from 
a 40-kg pig suffering from PMWS on an Iowa farm 
(Fenaux et al., 2000) was used for the inoculation. At 
21 wk of age, all Landrace-PCV2 and Pietrain-PCV2 
pigs each received 5 mL (104.5 TCID50/mL) of ISU-
40895 PCV2 inoculum: 3 mL intranasally and 2 mL 
intramuscularly.
Anti-PCV2-IgG and -IgM Antibodies
Blood [12.5-mL Corvac serum separator tube (Tyco 
Healthcare Group LP, Mansfield, MA) and 7-mL BD 
Vacutainer tube containing 12 mg of K3 EDTA (BD, 
Franklin Lakes, NJ)] was collected periodically during 
the growing phase, on the day of inoculation, and on 
7, 14, and 21 DPI. Serum samples were tested by an 
ORF2-based PCV2 IgG ELISA as described previous-
ly (Nawagitgul et al., 2002) and by the IgM Ingezim 
PCV ELISA (Ingenasa, Madrid, Spain). For the IgG 
ELISA, serum samples were considered positive if the 
calculated sample-to-positive (S/P) ratio was 0.2 or 
greater (Nawagitgul et al., 2002). For the IgM-ELISA, 
serum samples were considered positive on the IgM In-
gezim PCV ELISA if the optical density (OD) value 
was greater than the OD 450-nm value of the positive 
control × 0.4 as recommended by the manufacturer.
Neutralizing PCV2 Antibodies
A fluorescence focus neutralization assay was done 
on serum samples collected on the day of inoculation 
and at 7, 14, and 21 DPI to determine the presence 
of neutralizing antibodies against PCV2 according to 
the standard Iowa State University Veterinary Diag-
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nostic Laboratory operating protocol (Pogranichnyy et 
al., 2000). All samples were retested 3 times to confirm 
repeatability. The assay was performed with PCV2 iso-
late ISU-98–15237.
PCV2 DNA Quantification
The DNA extraction on serum samples collected on 
the day of inoculation and at 7, 14, and 21 DPI was 
performed using the QIAamp DNA Mini Kit (Qiagen, 
Valencia, CA). The DNA extracts were used for quan-
tification of the PCV2 genomic DNA copy numbers by 
real-time PCR (Opriessnig et al., 2003).
Cytokine Assays
Plasma samples collected at the day of inoculation 
and at 7, 14, and 21 DPI were tested by ELISA for 
presence of interferon (IFN)-γ, IL-10 (Invitrogen/Bio-
source, Carlsbad, CA), and IFN-α (PBL Biomedical 
Laboratories, Piscataway, NJ; Petry et al., 2007). All 
assays were performed according to the specifications of 
the manufacturers. Samples were run at 1:10, 1:4, or 1:2 
dilutions (or a combination of these) of plasma (assay 
dependent), respectively.
Clinical Evaluation and Necropsy
After PCV2 inoculation, the pigs were evaluated 
daily for clinical signs including respiratory disease, en-
teric disease, and behavioral changes such as lethargy 
and inappetence. All pigs were necropsied at 24 wk of 
age (21 d post PCV2 inoculation). Macroscopic lung 
lesions, scored from 0 to 100% of the lung affected, and 
the size of lymph nodes, scored from 0 (normal) to 3 
(4 times the normal size), were estimated in a blind-
ed fashion as described previously (Opriessnig et al., 
2006a). Lungs were insufflated with fixative. Sections of 
lymph nodes (superficial inguinal, mediastinal, tracheo-
bronchial, mesenteric), tonsil, thymus, ileum, kidney, 
colon, spleen, and liver were collected at necropsy and 
fixed in 10% neutral-buffered formalin and routinely 
processed for histological examination.
Histopathology
Microscopic lesions were evaluated in a blinded fash-
ion. Lung sections were scored for the presence and se-
verity of interstitial pneumonia ranging from 0 (normal) 
to 6 (severe diffuse) as described previously (Halbur et 
al., 1995). Sections of heart, liver, kidney, brain, ileum, 
and colon were evaluated for the presence of lympho-
histiocytic inflammation and scored from 0 (none) to 
3 (severe). Lymphoid tissues including lymph nodes, 
tonsil, and spleen were evaluated for the presence of 
lymphoid depletion ranging from 0 (normal) to 3 (se-
vere) and histiocytic inflammation and replacement of 
follicles ranging from 0 (normal) to 3 (severe; Opriess-
nig et al., 2004a).
Immunohistochemistry
The immunohistochemistry (IHC) for detection of 
PCV2-specific antigen was performed on selected for-
malin-fixed and paraffin-embedded sections of lymph 
nodes (superficial inguinal, mediastinal, tracheobron-
chial, and mesenteric), tonsil, spleen, Peyer’s patches, 
and thymus using a rabbit polyclonal antiserum as de-
scribed previously (Sorden et al., 1999). The PCV2-an-
tigen scoring was done in a blinded fashion, and scores 
ranged from 0 = no signal to 3 = more than 50% of 
the lymphoid follicles contain cells with PCV2-antigen 
staining (Opriessnig et al., 2004a).
Overall Microscopic Lymphoid Lesion Score
The overall microscopic lymphoid lesions score, which 
accounts for lymphoid depletion, histiocytic inflamma-
tion, and PCV2-antigen present in lymphoid tissues 
were calculated for each pig as described previously 
(Opriessnig et al., 2004a) and ranged from 0 = nor-
mal to 9 = severe. Pigs were grouped into 4 categories 
on the basis of the overall microscopic lymphoid lesion 
score: normal (score = 0), mild (score = 1 to 3), moder-
ate (score = 4 to 6), and severe (score = 7 to 9).
Statistical Analysis
Summary statistics were calculated for all groups to 
assess the overall quality of the data, including normal-
ity. Repeated measures multivariate ANOVA was per-
formed using the general linear model (GLM) function 
(SAS Institute Inc., Cary, NC) for assessment of con-
tinuous data with the null hypothesis of no differences 
over time between group means. For the model, the 
dependent factor was log10 genomic copies/mL, anti-
IgG sample-to-positive ratio, anti-IgM OD value, or the 
fluorescence focus neutralization assay titer. Fixed ef-
fects were sex (male and female), breed (Landrace and 
Pietrain), and status (control and PCV2 infected). The 
repeated variable was time. If an overall significant dif-
ference in time was noted (the rejection level for the 
null hypothesis was 0.05), a 3-way factorial ANOVA 
was performed at each time point to determine on 
which specific day(s) the dependent variables had a sig-
nificant effect. This procedure was done using the GLM 
procedure of SAS with sex, status, and breed, and all 
associated interactions as independent variables. Sig-
nificant effects of a factor were noted as a P < 0.05. 
To summarize and simplify the histopathological data, 
response feature analysis was used to condense lesions 
scores from various tissues into a single score per animal 
as described (Opriessnig et al., 2004a). The GLM pro-
cedure of SAS was used on the generated lesion score as 
described above. To analyze the effect of the sow on the 
initial anti-PCV2-IgG concentrations, the GLM proce-
dure of SAS was run separately for each breed, Pietrain 
and Landrace. For this analysis, the model included 
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effects for sow only; the anti-PCV2 concentration was 
considered the independent variable.
RESULTS
Clinical Evaluation and Macroscopic Lesions
None of the pigs in any of the groups developed clini-
cal disease throughout the duration of the study. Mac-
roscopic lesions were limited to enlarged lymph nodes 
and noncollapsed, mottled-tan lungs in individual pigs 
without statistical differences between groups.
Histopathology
In Table 1, the group means (±SE) for the amount 
of PCV2 antigen by IHC staining, degree of lymphoid 
depletion, and degree of histiocytic replacement in 
selected lymphoid tissues are summarized. In the Pi-
etrain-PCV2 group, 65.4% had normal lymphoid tis-
sues, 34.6% had occasional mild depletion of follicles in 
individual lymph nodes associated with low numbers 
of PCV2-antigen, and none of the pigs had moderate 
or severe PCV2-asssociated lesions. Individual Lan-
drace pigs (30.7%), however, had moderate-to-severe 
lymphoid depletion and histiocytic replacement in lym-
phoid tissues and moderate lymphohistiocytic infiltra-
tion in liver and heart tissues. These pigs originated 
from 5 different sires. In comparison with Landrace-
NEG and Pietrain-NEG, Landrace-PCV2 and Pietrain-
PCV2 had significantly greater overall severity of lym-
phoid lesions scores (P < 0.0001; Figure 1) and more 
severe interstitial pneumonia scores (P = 0.002; data 
not shown). Within the PCV2-inoculated groups, Pi-
etrain-PCV2 animals had significantly less overall se-
verity of lymphoid lesions scores than Landrace-PCV2 
animals (P = 0.02; Figure 1). Furthermore, 6 pigs, 5 
pigs, and 1 pig in the Landrace-PCV2 group had mild, 
moderate, and severe lymphoid lesions, respectively. In 
contrast, 9 Pietrain-PCV2 animals had mild, whereas 
none had moderate or severe, overall lymphoid lesions 
(Figure 2).
Anti-PCV2-IgM and -IgG Antibodies
All pigs had passively acquired IgG antibodies to 
PCV2 at arrival in the research facility at 3 wk of age. 
The mean-group anti-PCV2-IgG antibodies waned to 
negative concentrations around 12 wk of age in Pietrain 
pigs (at this time point 18/39 Landrace pigs and 0/39 
Pietrain pigs had S/P ratios above the cut-off) and 
around 18 wk of age in Landrace pigs (5/39 Landrace 
pigs and 0/39 Pietrain pigs had S/P ratios above the 
cut-off). On the day of PCV2 inoculation (21 wk of 
age), all pigs were negative for anti-PCV2-IgM and 
-IgG antibodies.
Anti-porcine circovirus type 2-IgM optical densities 
from 0 to 21 DPI for all groups are summarized in Fig-
ure 3. The Landrace-NEG and Pietrain-NEG groups did 
not develop detectable anti-PCV2 antibodies through-
out the study, whereas Landrace-PCV2 and Pietrain-
Table 1. Group mean (±SE) for porcine circovirus type 2 (PCV2) immunohistochemical staining (IHC), lymphoid 
depletion (LD), and histiocytic replacement (HR) in selected lymphoid tissues 
Item Landrace-NEG1 Pietrain-NEG Landrace-PCV2 Pietrain-PCV2
Lymph node
 PCV2 IHC2 0.00 (±0.00)A 0.00 (±0.00)A 0.54 (±0.17)B 0.08 (±0.05)A
 LD3 0.00 (±0.00)A 0.15 (±0.10)A 1.04 (±0.21)B 0.23 (±0.12)A
 HR3 0.00 (±0.00)A 0.08 (±0.08)A 0.81 (±0.18)B 0.23 (±0.10)A
Tonsil
 PCV2 IHC2 0.00 (±0.00)A 0.00 (±0.00)A 0.42 (±0.15)B 0.19 (±0.10)BA
 LD3 0.00 (±0.00)A 0.00 (±0.00)A 0.46 (±0.14)B 0.04 (±0.04)A
 HR3 0.00 (±0.00)A 0.00 (±0.00)A 0.38 (±0.14)B 0.04 (±0.04)A
Spleen
 PCV2 IHC2 0.00 (±0.00)A 0.00 (±0.00)A 0.08 (±0.05)A 0.04 (±0.04)A
 LD3 0.08 (±0.08)A 0.00 (±0.00)A 0.58 (±0.16)B 0.15 (±0.07)A
 HR3 0.08 (±0.08)A 0.00 (±0.00)A 0.50 (±0.16)B 0.15 (±0.09)BA
A,BMeans within row with different superscripts are significantly different (P < 0.05).
1NEG = noninoculated negative control.
2Scores range from 0 (no signal) to 3 (more than 50% of the lymphoid follicles contain cells with PCV2-antigen staining).
3Scores ranged from 0 (normal) to 3 (severe).
Figure 1. Mean group overall lymphoid lesion score (lymphoid 
depletion, histiocytic replacement, amount of porcine circovirus type 
2 (PCV2)-antigen as determined by immunohistochemistry) 21 d post 
PCV2 inoculation. NEG = noninoculated negative control. Data are 
presented as group means ± SE. A–CColumns that are connected by 
different letters are significantly (P < 0.05) different from each other.
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PCV2 groups developed anti-PCV2-IgM antibodies by 
DPI 14. Within the PCV2-inoculated animals, there 
were no significant differences between OD ratios in 
Landrace and Pietrain at any DPI (P > 0.05).
Anti-porcine circovirus type 2-IgG S/P ratios from 0 
to 21 DPI for all groups are summarized in Figure 4. 
The Landrace-NEG and Pietrain-NEG groups did not 
develop anti-PCV2-IgG antibodies within the obser-
vation period, whereas Landrace-PCV2 and Pietrain-
PCV2 groups seroconverted by DPI 14. Within the 
PCV2-inoculated animals, there were no significant dif-
ferences in OD ratios between Landrace and Pietrain 
groups at any DPI (P > 0.05).
Neutralizing PCV2 Antibodies
During the observation period from the day of inocu-
lation until 14 DPI, there were no differences in mean 
group anti-PCV2-neutralizing antibody concentrations 
between PCV2-infected groups/breeds (data not shown). 
On DPI 21, PCV2-infected pigs had significantly (P < 
0.001) greater mean group concentrations of anti-PCV2 
neutralizing antibodies compared with noninfected pigs 
regardless of breed [log10 ± SE: Landrace-NEG (1.06 
± 0.12); Pietrain-NEG (0.88 ± 0.06); Landrace-POS 
(1.68 ± 0.08); Pietrain-POS (1.78 ± 0.09)]. The corre-
lation coefficients (r) between the amount of anti-PCV2 
neutralizing antibodies and overall severity of lymphoid 
lesions score were 0.12 and 0.01 for PCV2-infected pigs 
and noninfected pigs, respectively, regardless of breed. 
By breed, the Landrace-PCV2 group had a correlation 
coefficient of 0.31, whereas the Pietrain-PCV2 group 
had a correlation coefficient of 0.03.
Amount of PCV2 DNA in Serum Samples
Quantitative PCV2 PCR data for all groups is sum-
marized in Figure 5. All pigs in all groups were PCV2 
DNA negative in serum samples on the day of PCV2 
inoculation at 21 wk of age. The Landrace-NEG and 
Pietrain-NEG groups remained PCV2 DNA negative 
at DPI 7, 14, and 21. Within the PCV2-inoculated 
animals, the amount of PCV2 DNA in serum was not 
significantly different between Landrace-PCV2 and Pi-
etrain-PCV2 groups at DPI 7, 14, or 21 (P = 0.15, 0.15, 
and 0.58, respectively). The correlation coefficients be-
tween the amount of anti-PCV2 neutralizing antibodies 
at DPI 21 and the amount of PCV2 DNA in serum at 
DPI 21 were 0.32 and 0.00 for PCV2-infected pigs and 
noninfected pigs, respectively, regardless of breed. The 
correlation coefficients between the amount of the over-
all severity of lymphoid lesions score and the amount of 
PCV2 DNA in serum at DPI 21 were 0.54 and 0.00 for 
PCV2-infected pigs and noninfected pigs, respective-
ly, regardless of breed. By breed, the Landrace-PCV2 
group had a correlation coefficient of 0.48, whereas the 
Pietrain-PCV2 group had a correlation coefficient of 
0.38. The correlation coefficients between the amount 
of IFN-γ at DPI 21 and the amount of PCV2 DNA in 
serum at DPI 21 was 0.00 and 0.00 for PCV2-infected 
pigs and noninfected pigs, respectively, regardless of 
breed.
Selected Cytokine Concentrations  
in Plasma Samples
There were no significant differences in mean group 
amount of plasma IFN-γ concentrations, plasma IL-
10 concentrations, and plasma IFN-α concentrations 
within the Landrace-PCV2 and Pietrain-PCV2 groups 
at DPI 21 (P = 0.99, 0.33, and 1.00, respectively; data 
Figure 2. Percentage of Landrace and Pietrain pigs inoculated 
with porcine circovirus type 2 (PCV2) within the overall microscopic 
lymphoid lesion category normal (score = 0), mild (score = 1 to 3), 
moderate (score = 4 to 6), and severe (score = 7 to 9).
Figure 3. Mean group optical density (OD) ratios for anti-porcine 
circovirus type 2 (PCV2)-IgM antibody response on the day of inocu-
lation, and at 7, 14, and 21 d postinoculation. NEG = noninoculated 
negative control.
Figure 4. Mean group anti-porcine circovirus type 2 (PCV2)-IgG 
sample-to-positive (S/P) ratios on the day of inoculation, and at 7, 14, 
and 21 d postinoculation. A sample-to-positive ratio equal or above 0.2 
is considered positive. NEG = noninoculated negative control.
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not shown). In addition, there was no statistically sig-
nificant correlation of DPI 21 plasma IFN-γ concentra-
tions, plasma IL-10 concentrations, and plasma IFN-α 
concentrations and severity of lymphoid lesions in any 
of the pigs (data not shown).
DISCUSSION
Currently there is great interest from veterinarians, 
producers, and pig genetic companies to determine if a 
genetic host component influences PCV2 susceptibil-
ity and manifestation of PCVAD. Although effective 
PCV2 vaccines recently reached the market (Fachinger 
et al., 2008; Fort et al., 2008; Opriessnig et al., 2008), 
these products require additional labor and increased 
costs for producers. If a traceable genetic marker for 
PCVAD resistance were discovered, targeted breed-
ing and genetic manipulation may facilitate reductions 
in PCVAD and negate the need for PCV2 vaccines in 
some swine herds. However, the scientific community 
is still at the beginning of understanding host genetic 
resistance to disease in pigs.
A cohort study was conducted to investigate a sus-
pected decreased susceptibility to PCVAD in Pietrain 
pigs by manipulating the herd genetics via AI on 4 clin-
ically affected farms (Rose et al., 2004). One-half of the 
sows were inseminated with Pietrain semen, whereas 
the remaining sows received the semen that was typi-
cally used on these farms. The PCV2-seroconversion, 
morbidity, and mortality were similar in the Pietrain 
offspring compared with the other pigs on these farms 
(Rose et al., 2004).
In Canada, 43 boars located in one boar stud were 
tested for the presence of PCV2 DNA in semen (McIn-
tosh et al., 2006). Duroc and Landrace boars were 
found to be positive for PCV2-DNA in semen, whereas 
Large White and Meishan synthetic breeds did not shed 
PCV2 DNA in semen (McIntosh et al., 2006). On 46 
swine farms in Zhejian, China, 44.83% of all Landrace 
sows and 64.28% of all Landrace piglets were positive 
for PCV2 antibodies, values greater than observed in 
Yorkshire and Duroc sows (Zhou et al., 2006).
López-Soria et al. (2004) compared the effect of 3 
different genetic boar lines (100% Pietrain, 50% Large 
White/50% Pietrain, and 25% Large White/75% Du-
roc) at 2 Spanish farms on the outcome of overall and 
PCV2-associated postweaning mortality and found a 
significant effect of host genetics on the manifestation of 
PCVAD; however, due to the limited size of the study, 
it could not be definitely concluded that the observed 
effect was due to a particular breed/line or a particular 
boar (Lopéz-Soria et al., 2004). Sibila et al. (2005) com-
pared the amount of PCV2 DNA in sera from pigs in 
the same Spanish herds as used in the study by Lopéz-
Soria et al. (2004) and found that the PCV2 DNA load 
correlated with genetic background and that 1 of the 3 
paternal genetic lines (25% Large White/75% Duroc) 
had the greatest PCV2 loads in serum samples at 9 and 
21 wk of age (Sibila et al., 2005). Overall, it needs to be 
considered that a genetic component most likely is not 
confined to a certain breed or gene locus and that not 
all lines within a breed express all necessary genes.
By expanding our previous study (Opriessnig et al., 
2006a), we tested additional pig breeds and further 
confirmed that differences in susceptibility to PCV2-
associated lesions exist between pigs of different genetic 
background. This controlled study further confirms a 
genetic component in susceptibility to PCV2 infection 
and disease. In the present study, experimental PCV2 
inoculation was done at 21 wk of age. This is relatively 
late in the production cycle and past the time at which 
pigs are most likely naturally exposed to PCV2 in the 
field; however, Landrace pigs still developed moderate-
to-severe PCV2-associated lesions. One of the Lan-
drace pigs had lesions compatible with PMWS (overall 
lymphoid lesion score of 7), and 2 Landrace pigs had 
moderate PCV2-associated lesions (overall lymphoid 
lesion score of 6). No clinical signs were observed in the 
present study; however, this is not surprising because 
clinical signs in pigs infected by PCV2 alone are rarely 
produced. The observed lesions were similar to lesions 
seen in cases of naturally occurring or experimentally 
induced systemic PCVAD in much younger animals. 
This implies that the assumption that older pigs are 
more resistant to PCVAD may be wrong and that ex-
pression of disease and lesions is more related to timing 
of infection.
Interestingly, although the pigs originated on the 
same farm, maternal anti-PCV2-antibodies waned in 
the Pietrain pigs by approximately 12 wk of age, where-
as the majority of the Landrace pigs remained PCV2 
seropositive until 18 wk of age and beyond. It has been 
estimated previously that the mean antibody half-life 
of passively derived PCV2 antibodies is approximately 
19 d (Opriessnig et al., 2004b), which implies that the 
Landrace piglets received considerably greater concen-
trations of anti-PCV2-antibodies via the colostrum 
compared with the Pietrain piglets. Alternatively, the 
anti-PCV2-antibodies in Landrace pigs may have been 
degraded more slowly than in the Pietrain pigs.
It has been demonstrated that maternally derived 
anti-PCV2-antibodies are protective from developing 
Figure 5. Amount of porcine circovirus type 2 (PCV2) genomic 
copies per milliliter of serum in PCV2-inoculated groups on the day of 
inoculation, and at 7, 14, and 21 d postinoculation. Data are presented 
as log10 transformed group means.
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clinical PCVAD (Allan et al., 2002). In that field study 
and under study conditions during the observation pe-
riod, none of the piglets derived from the dams with 
high PCV2-antibodies developed PMWS, and 60% of 
the piglets that did develop PMWS were derived from 
the dams with the least PCV2 serum antibody concen-
trations (Allan et al., 2002). Another European field 
study investigated the effect of the sow on PMWS in 
a cohort study in 3 sow herds with high postweaning 
mortality due to PMWS (Hassing et al., 2003). A total 
of 1,226 piglets derived from 122 sows were included in 
this study. It was found that the offspring from sows 
with increased antibody concentrations against PCV2 
at farrowing had a greater risk of dying after weaning. 
The risk of dying was also dependent on increasing titers 
against PCV2 from weaning until 4 wk after weaning 
(Hassing et al., 2003). Furthermore, it has been previ-
ously shown that decreased concentrations of passively 
acquired antibodies do not prevent PCV2 replication 
(McKeown et al., 2005) and subclinically infected pigs 
may serve as a continuous source of PCV2.
It can be speculated that pigs that are more suscep-
tible to PCVAD, but survive the growing phase, have 
greater amounts of antibodies and therefore pass on 
greater concentrations of colostral-antibodies to their 
offspring. Interestingly, the data in our study are sup-
ported by a recent Chinese field study that found a 
trend toward greater prevalence of anti-PCV2-antibod-
ies in Landrace sows compared with Yorkshire and Du-
roc sows (Zhou et al., 2006).
The mechanism of progression of PCV2 infection to 
clinical disease and the pathogenesis of PCV2-infection 
in general remain poorly understood. We previously 
investigated the immune gene expression profiles in 
tracheobronchial lymph nodes after experimental in-
fection with PCV2, Mycoplasma hyopneumoniae, and 
PCV2/M. hyopneumoniae coinfection and compared 
the profiles with those of uninfected controls (Opriess-
nig et al., 2006b). We found that single PCV2 infection 
was characterized by significantly increased IFN-γ and 
IL-8 chemokine gene expression and speculated that 
upregulation of certain cytokines during the course of 
inflammation above a certain level would influence the 
concentration and type of antibodies produced in re-
sponse to infection, resulting in PCVAD (Opriessnig 
et al., 2006b). Inappropriate and ineffective cytokine 
production could be associated with failure to produce 
sufficient concentrations of neutralizing antibodies to 
control the PCV2. One possible mechanism of this fail-
ure is by a lack of isotype switching of IgM antibodies 
to IgG antibodies. The IFN-γ stimulates expression of 
both MHC class I and II molecules and co-stimulates 
and promotes B cell switching to certain Ig subclass-
es, and concurrently inhibits the antibodies associated 
with a T helper 2-like antibody response, which would 
include less efficacious antibodies such as IgE. In our 
current study, we did not find a breed-dependent differ-
ence in expression of selected cytokines, nor did we find 
a correlation with plasma concentrations of selected 
cytokines and overall lymphoid lesions scores. Plasma 
IFN-γ, IL-10, and IFN-α concentrations were not dif-
ferent in pigs with moderate-to-severe overall lymphoid 
lesions compared with control pigs. The lack of overall 
plasma cytokine correlation is in contrast to previous 
field observations (Darwich et al., 2003; Sipos et al., 
2004); a likely explanation would be the lack of concur-
rent pathogens in our controlled experimental study. In 
addition, these pigs were infected at 21 wk of age when 
their immune system was more fully developed.
It has recently been demonstrated that PCVAD-af-
fected pigs have decreased concentrations of neutraliz-
ing antibodies compared with clinically unaffected pigs 
(Meerts et al., 2006). Neutralizing antibodies were de-
tected between 15 d (Meerts et al., 2005, 2006) and 28 
d (Pogranichnyy et al., 2000) post PCV2 infection and 
were correlated with protection or clearance of PCV2 
infection in gnotobiotic pigs (Meerts et al., 2006). One 
possible mechanism of the lack of serum neutralizing 
antibody production is through impaired antibody iso-
type switching. The PCV2-specific IgM antibodies have 
been shown to appear within the first few weeks after 
PCV2 infection, followed by isotype switching to pre-
dominately IgG production starting at approximately 
14 d post PCV2 infection. Pigs that develop PCVAD 
have been shown to remain seronegative for PCV2-
specific IgG (Opriessnig et al., 2004a), suggesting that 
the normal switching process has been circumvented. In 
this study, we tested neutralizing antibodies to deter-
mine if differences in neutralizing antibody concentra-
tions could be correlated with breed and differences in 
disease susceptibility. Differences in anti-PCV2 serum 
neutralizing antibody concentrations were not observed 
between the 2 breeds. Furthermore, there was no ap-
parent correlation with overall lymphoid lesion severity 
and amount of anti-PCV2 serum neutralizing antibod-
ies. This may be due to the timing of necropsy (21 
DPI), which may have been too early in the course 
of neutralizing antibody induction and production for 
demonstrating significant differences between groups. 
Interestingly, the pigs with the greatest amount of anti-
PCV2 neutralizing antibodies at the time of necropsy 
had an overall lymphoid score of zero, whereas the pig 
with the greatest overall lymphoid score (score = 7) 
was negative for anti-neutralizing antibodies.
In summary, the results from this study indicated 
that a sampled group of Landrace pigs are more suscep-
tible to PCV2-associated lesions. We also demonstrated 
that a sampled group of Pietrain pigs are less suscep-
tible to PCV2-associated lesions, which supports anec-
dotal reports from the field. The body of evidence to 
support the need for more detailed genetic work in this 
area continues to grow. Use of new genomic technolo-
gies should to be used to determine if individual alleles 
or groups of alleles from several genes differ between 
breeds and are associated with the apparent breed dif-
ferences seen here and in other studies.
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